Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Non-randomised Trial of Chemotherapy and Radiotherapy for Osteolymphoma

NCT00141648 is registered in ClinicalTrials.gov with Trans Tasman Radiation Oncology Group as lead sponsor.

NCT NCT00141648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00141648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Non-randomised Trial of Chemotherapy and Radiotherapy for Osteolymphoma
Lead sponsor
Trans Tasman Radiation Oncology Group
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2000
Completion date
February 29, 2008
Enrollment
70 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

osteolymphoma